European equities traded in the US as American depositary receipts were climbing sharply late Friday morning, rising 2.45% to 1,423.12 on the S&P Europe Select ADR Index, which is up 2.3% for the week.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and financial services company ING Groep (ING), which advanced 8.9% and 7.5%, respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Grifols (GRFS), which rose 5.9% and 4.4%, respectively.
The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and telecommunications operator Telefonica (TEF), which fell 11% and 1.5%, respectively. They were followed by furniture maker Natuzzi (NTZ) and oil and gas company TotalEnergies (TTE), which were down 1.2% and 0.4%, respectively.
From the UK and Ireland, the gainers were led by biotech firms Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which were up 3.8% and 3.5%, respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which increased 3.3% and 3.2%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which dropped 2.1% and 1.4%, respectively. They were followed by tobacco company British American Tobacco (BTI) and telecommunications operator Vodafone Group (VOD), which lost 0.2% and 0.1%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。